EQUITY - Embodiment, social ineQualities, lifecoUrse epidemiology, cancer and chronIc diseases, intervenTions, methodologY
Equipe constitutive du CERPOP, UMR1295, unité mixte INSERM - Université Toulouse III Paul Sabatier
Pacale GROSCLAUDE •  chercheure

  1. Bielska-Lasota M, Rossi S, Krzyżak M, et al  EUROCARE-5 Working Group (Grosclaude P collaborator). Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study [published online ahead of print, 2019 Dec 18]. Arch Gynecol Obstet. 2019;10.1007/s00404-019-05412-5. doi:10.1007/s00404-019-05412-5.
  2. Bouvier AM, Robaszkiewicz M, Jooste V, et al. French Network of Cancer Registries (FRANCIM (Grosclaude P collaborator). Trends in incidence of small bowel cancer according to histology: a population-based study [published online ahead of print, 2019 Oct 19]. J Gastroenterol. 2019;10.1007/s00535-019-01636-z. doi:10.1007/s00535-019-01636-z
  3. Bryere J, Tron L, Menvielle G, Launoy G; French Network of Cancer Registries (FRANCIM) (Grosclaude P collaborator). The respective parts of incidence and lethality in socioeconomic differences in cancer mortality. An analysis of the French network Cancer registries (FRANCIM) data. Int J Equity Health. 2019 Dec 3;18(1):189. doi: 10.1186/s12939-019-1087-y.
  4. Cowppli-Bony A, Colonna M, Ligier K, Jooste V, Defossez G, Monnereau A; le Réseau Francim; Réseau des registres de cancer Francim. Grosclaude P collaborator) [Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence]. Bull Cancer. 2019. Jul-Aug 106 (7-8), 617-63. doi: 10.1016/j.bulcan.2018.11.016.
  5. Gatta G, Trama A, Capocaccia R; RARECARENet Working Group. (Grosclaude P collaborator) Epidemiology of rare cancers and inequalities in oncologic outcomes. Eur J Surg Oncol. 2019 Jan;45(1):3-11. doi: 10.1016/j.ejso.2017.08.018.
  6. Gosset A, Cohade C, Grosclaude P, Oumsack E, Dalenc F, Montagut M, Parinaud J, Vaysse C. [Regional state-of-the-art of the access to oncofertility consultation for young women with breast cancer]. Gynecol Obstet Fertil Senol. 2019 Oct;47(10):732-738. doi:10.1016/j.gofs.2019.08.005.
  7. Imbimbo M, Maury JM, Garassino M, Girard N; RARECAREnet Working Group. (Grosclaude P collaborator)  Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting. Eur J Surg Oncol. 2019 Jan;45(1):75-80. doi: 10.1016/j.ejso.2018.01.078.
  8. Lamy S, Guimbaud R, Digue L, Cirilo-Cassaigne I, Bousser V, Oum-Sack E, Goddard J, Bauvin E, Delpierre C, Grosclaude P; EvaCCoR Group. Are there variations in adherence to colorectal cancer clinical guidelines depending on treatment place and recommendation novelty? The French EvaCCoR observational study. Clin Res Hepatol Gastroenterol. 2019 Jun;43(3):346-356. doi: 10.1016/j.clinre.20110.008.
  9. Lamy S, Laurent G, Lepage B, Grosclaude P, Delpierre C. Impact of comorbidity in DBLCL: direct and indirect effects on survival through unplanned chemotherapy dose reduction. J Intern Med. 2019 Apr;285(4):472-474. doi: 10.1111/joim.12879.
  10. Lamy S, Molinié F, Daubisse-Marliac L, Cowppli-Bony A, Ayrault-Piault S, Fournier E, Woronoff AS, Delpierre C, Grosclaude P. Using ecological socioeconomic position (SEP) measures to deal with sample bias introduced by incomplete individual-level measures: inequalities in breast cancer stage at diagnosis as an example. BMC Public Health. 2019 Jul 2;19(1):857. doi: 1186/s12889-019-7220-4.
  11. Lykoudis PM, Partelli S, Muffatti F, Caplin M, Falconi M, Fusai GK; RARECARENet Working Group. (Grosclaude P collaborator) Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours. Eur J Surg Oncol. 2019 Jan;45(1):46-51. doi: 10.1016/j.ejso.2017.08.019.
  12. Nicolai N, Biasoni D, Catanzaro MA, Colecchia M, Trama A; RARECAREnet Working Group. (Grosclaude P collaborator) Testicular germ-cell tumours and penile squamous cell carcinoma: Appropriate management makes the difference. Eur J Surg Oncol. 2019 Jan;45(1):60-66. doi: 10.1016/j.ejso.2018.02.006.
  13. Orlandi E, Alfieri S, Simon C, Trama A, Licitra L; RARECAREnet Working Group. (Grosclaude P collaborator) Treatment challenges in and outside a network setting: Head and neck cancers. Eur J Surg Oncol. 2019 Jan;45(1):40-45. doi: 10.1016/j.ejso.2018.02.007.
  14. Pasquali S, Bonvalot S, Tzanis D, Casali PG, Trama A, Gronchi A; RARECARENet Working Group. (Grosclaude P collaborator) Treatment challenges in and outside a network setting: Soft tissue sarcomas. Eur J Surg Oncol. 2019 Jan;45(1):31-39. doi: 10.1016/j.ejso.2017.09.015.
  15. Piel C, Pouchieu C, Carles C, Béziat B, Boulanger M, Bureau M, Busson A, Grüber A, Lecluse Y, Migault L, Renier M, Rondeau V, Schwall X, Tual S; AGRICAN group (Grosclaude P collaborator), Pierre L, Baldi I. Agricultural exposures to carbamate herbicides and fungicides and central nervous system tumour incidence in the cohort AGRICAN. Environ Int. 2019 Sep;130:104876. doi:10.1016/j.envint.2019.05.070.
  16. Pons-Tostivint E, Daubisse-Marliac L, Grosclaude P, Oum Sack E, Goddard J, Morel C, Dunet C, Sibrac L, Lagadic C, Bauvin E, Bergé Y, Bernard-Marty C, Vaysse C, Lacaze JLL; EvaSein Group. Multidisciplinary team meeting and EUSOMA quality indicators in breast cancer care: A French regional multicenter study. Breast. 2019 Aug;46:170-177. doi: 10.1016/j.breast.2019.06.001.
  17. Ray-Coquard I, Trama A, Seckl MJ, Fotopoulou C, Pautier P, Pignata S, Kristensen G, Mangili G, Falconer H, Massuger L, Sehouli J, Pujade-Lauraine E, Lorusso D, Amant F, Rokkones E, Vergote I, Ledermann JA; RARECARENet Working Group. (Grosclaude P collaborator). Rare ovarian tumours: Epidemiology, treatment challenges in and outside a network setting. Eur J Surg Oncol. 2019 Jan;45(1):67-74. doi: 10.1016/j.ejso.2009.025.
  18. Tual S, Busson A, Boulanger M, Renier M, Piel C, Pouchieu C, Pons R, Perrier S, Levêque-Morlais N, Karuranga P, Lemarchand C; AGRICAN-Group (Grosclaude P collaborator), Marcotullio E, Guizard AV, Monnereau A, Baldi I, Lebailly P. Occupational exposure to pesticides and multiple myeloma in the AGRICAN cohort. Cancer Causes Control. 2019 Nov;30(11):1243-1250. doi:10.1007/s10552-019-01230-x.